Translating cell therapy manufacturing
Will integrated automation transform speed and efficiency for cell therapy products while minimizing risk?
The advanced therapies pipeline has exploded, with new medicinal products achieving remarkable patient outcomes. But the future was never guaranteed. In this video series, the people who paved the way for the earliest therapeutics share their inspiring journey from discovery to delivery.
Watch the seriesWill integrated automation transform speed and efficiency for cell therapy products while minimizing risk?
When your mRNA process challenges start to feel out of control, we'll help you find firm ground.
Cytiva continues to navigate the changes and innovations in oligonucleotides and genetic editing.
We bring together insights to help you develop a scalable and cost-efficient manufacturing process.
How reliable lipid nanoparticle (LNP) production will help move promising nucleic acid candidates to market.
Keys to success for oligonucleotide medicinal products.
What’s next for mRNA? The future looks bright ― just ask this team of pioneers and visionaries.
Improving human health with biotechnology while protecting the planet.